NCT04318327View on ClinicalTrials.gov

BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma

PHASE1TerminatedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

July 23, 2020

Primary Completion Date

April 29, 2025

Study Completion Date

April 29, 2025

Conditions
Multiple Myeloma
Interventions
BIOLOGICAL

PHE885

Infusion

Trial Locations (9)

3004

Novartis Investigative Site, Melbourne

53226

Medical College of Wisconsin, Milwaukee

60637

Uni of Chi Medi Ctr Hema and Onco, Chicago

119074

Novartis Investigative Site, Singapore

169608

Novartis Investigative Site, Singapore

5265601

Novartis Investigative Site, Ramat Gan

6423906

Novartis Investigative Site, Tel Aviv

02215

Beth Israel Deaconess Medical Cente, Boston

Dana Farber Cancer Institute, Boston

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY